Reuters logo
7 months ago
BRIEF-Tapimmune launches Phase 2 ovarian cancer trial in platinum-sensitive patients
January 10, 2017 / 3:10 PM / 7 months ago

BRIEF-Tapimmune launches Phase 2 ovarian cancer trial in platinum-sensitive patients

Jan 10 (Reuters) - Tapimmune Inc :

* Tapimmune launches Phase 2 ovarian cancer trial in platinum-sensitive patients Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below